Pharos iBio파로스아이바이오
388870 · KOSDAQ · ₩388870 · 파로스아이바이오
₩5,890▲ ₩80 (1.38%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Gross margin | — | — | — | — |
| Operating margin | — | — | — | — |
| Net margin | — | — | — | — |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue growth | — | — | — | — |
| Operating income growth | +8.1% | +8.7% | −24.6% | — |
| Net income growth | +12.9% | −3.4% | −16.0% | — |
Returns
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Return on equity | −78.9% | −65.8% | −44.1% | −31.5% |
| Return on assets | −33.8% | −43.5% | −42.8% | −29.8% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Liabilities to equity | 170.1% | 114.5% | 5.5% | 4.7% |
| Net debt to equity | 32.5% | −127.8% | −33.5% | −55.0% |
| Current ratio | 2,833.4% | 1,895.8% | 1,670.1% | 2,156.9% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Pharos iBio / 파로스아이바이오 / 388870 / KRX:388870
Source: KRX statistical information